Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 125 to 174 of 6456 in total 
Value Type: Measured
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Network Comparison Type\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
63\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
myosin xv (unconventional myosin-15). [source:swissprot;acc:q9ukn7]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4489.19\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2765.82\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.6231\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
spermatogenesis associated 6. [source:refseq;acc:nm\_019073]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6475.5\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
10307.5\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
3832\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
64\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
amp deaminase 2 (ec 3.5.4.6) (amp deaminase isoform l). [source:swissprot;acc:q01433]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
glycogen phosphorylase, muscle form (ec 2.4.1.1) (myophosphorylase). [source:swissprot;acc:p11217]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4489.19\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2765.82\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.6231\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
65\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cleavage stimulation factor subunit 3; cleavage stimulation factor, 3' pre-rna, subunit 3, 77kd. [source:refseq;acc:nm\_001326]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
22515.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
18702.6\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3812.9\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
neuralized-like. [source:refseq;acc:nm\_004210]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1657.68\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2690.25\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.6229\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
66\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
a-raf proto-oncogene serine/threonine-protein kinase (ec 2.7.1.-) (a-raf-1) (proto-oncogene pks). [source:swissprot;acc:p10398]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
17757.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
14008\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3749.5\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
nadh-ubiquinone oxidoreductase subunit b17.2 (ec 1.6.5.3) (ec 1.6.99.3) (complex i-b17.2) (ci-b17.2) (cib17.2) (13 kda differentiation-associated protein). [source:swissprot;acc:q9ui09]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
1991.03\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
3221.38\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.61795\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
67\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
beta-arrestin 2 (arrestin, beta 2). [source:swissprot;acc:p32121]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6475.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10307.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.59177\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
raf proto-oncogene serine/threonine-protein kinase (ec 2.7.1.-) (raf-1) (c-raf). [source:swissprot;acc:p04049]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
17756.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
14007.3\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3749.2\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
68\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
beta-arrestin 1 (arrestin, beta 1). [source:swissprot;acc:p49407]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6475.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10307.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.59177\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
cyclin g2. [source:swissprot;acc:q16589]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
17738.6\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
13995.7\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
3742.9\vspace{3pt}}}\\\cline{1-2}\cline{4-5}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
69\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cyclin g1 (cyclin g). [source:swissprot;acc:p51959]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
17738.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
13995.6\vspace{3pt}}&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
spermatogenesis associated 6. [source:refseq;acc:nm\_019073]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6475.5\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
10307.5\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.59177\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
70\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
amp deaminase 2 (ec 3.5.4.6) (amp deaminase isoform l). [source:swissprot;acc:q01433]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine protein phosphatase 2a, 56 kda regulatory subunit, epsilon isoform (pp2a, b subunit, b' epsilon isoform) (pp2a, b subunit, b56 epsilon isoform) (pp2a, b subunit, pr61 epsilon isoform) (pp2a, b subunit, r5 epsilon isoform). [source:swissprot;acc:q16537]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
17738.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
13995.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3742.8\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
71\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine protein phosphatase 2a, 55 kda regulatory subunit b, alpha isoform (pp2a, subunit b, b-alpha isoform) (pp2a, subunit b, b55-alpha isoform) (pp2a, subunit b, pr55-alpha isoform) (pp2a, subunit b, r2-alpha isoform). [source:swissprot;acc:q00007]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4556.78\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2945.26\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.54716\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine protein phosphatase 2a, 56 kda regulatory subunit, alpha isoform (pp2a, b subunit, b' alpha isoform) (pp2a, b subunit, b56 alpha isoform) (pp2a, b subunit, pr61 alpha isoform) (pp2a, b subunit, r5 alpha isoform). [source:swissprot;acc:q15172]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
17738.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
13995.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3742.8\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
72\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
b-raf proto-oncogene serine/threonine-protein kinase (ec 2.7.1.-) (p94) (v-raf murine sarcoma viral oncogene homolog b1). [source:swissprot;acc:p15056]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
17710.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
13977.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3733.2\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
uncharacterized hematopoietic stem/progenitor cells protein mds026. [source:sptrembl;acc:q9nz48]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
4556.79\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2945.28\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.54715\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
73\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine protein phosphatase 2a, 55 kda regulatory subunit b, beta isoform (pp2a, subunit b, b-beta isoform) (pp2a, subunit b, b55- beta isoform) (pp2a, subunit b, pr55-beta isoform) (pp2a, subunit b, r2-beta isoform). [source:swissprot;acc:q00005]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
4556.83\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2945.38\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.54711\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine protein phosphatase pp1-gamma catalytic subunit (ec 3.1.3.16) (pp-1g). [source:swissprot;acc:p36873]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
22268.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
18560.4\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3708.4\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
74\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein hox-c4 (hox-3e) (cp19). [source:swissprot;acc:p09017]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
20446.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
24136.4\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3690.3\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine protein phosphatase 2a, 55 kda regulatory subunit b, gamma isoform (pp2a, subunit b, b-gamma isoform) (pp2a, subunit b, b55-gamma isoform) (pp2a, subunit b, pr55-gamma isoform) (pp2a, subunit b, r2-gamma isoform) (imypno1). [source:swissprot;acc:q9y2t4]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4556.99\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2945.8\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.54694\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
75\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein hox-b4 (hox-2f) (hox-2.6). [source:swissprot;acc:p17483]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
20446.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
24136.4\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3690.3\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
nadh-ubiquinone oxidoreductase 18 kda subunit, mitochondrial precursor (ec 1.6.5.3) (ec 1.6.99.3) (complex i-18 kda) (ci-18 kda) (complex i- aqdq) (ci-aqdq). [source:swissprot;acc:o43181]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1920.75\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2907.43\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.5137\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
76\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein hox-c5 (hox-3d) (cp11). [source:swissprot;acc:q00444]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
20446.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
24136.4\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3690.3\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine protein phosphatase 2a, 65 kda regulatory subunit a, beta isoform (pp2a, subunit a, pr65-beta isoform) (pp2a, subunit a, r1-beta isoform). [source:swissprot;acc:p30154]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4599.26\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
3058.57\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.50373\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
77\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein hox-c6 (hox-3c) (hho.c8) (cp25). [source:swissprot;acc:p09630]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
20446.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
24136.4\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3690.3\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine protein phosphatase 2a, 65 kda regulatory subunit a, alpha isoform (pp2a, subunit a, pr65-alpha isoform) (pp2a, subunit a, r1-alpha isoform) (medium tumor antigen-associated 61 kda protein). [source:swissprot;acc:p30153]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
4612.39\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
3093.6\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.49095\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
78\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cyclic-amp-dependent transcription factor atf-3 (activating transcription factor 3). [source:swissprot;acc:p18847]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
4800.81\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7132.71\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.48573\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein hox-d4 (hox-4b) (hox-5.1) (hho.c13). [source:swissprot;acc:p09016]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
20446.1\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
24136.4\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
3690.3\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
79\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein hox-b5 (hox-2a) (hho.c10) (hu-1). [source:swissprot;acc:p09067]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
protein cgi-126 (protein hspc155). [source:swissprot;acc:q9y3c8]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3074.57\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4567.51\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.48558\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
80\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein hox-a5 (hox-1c). [source:swissprot;acc:p20719]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
20446.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
24136.4\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3690.3\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
nucleolysin tia-1 (rna-binding protein tia-1) (p40-tia-1) [contains: p15-tia-1]. [source:swissprot;acc:p31483]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4133.47\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5945.32\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.43834\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
81\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein hox-a4 (hox-1d) (hox-1.4). [source:swissprot;acc:q00056]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
20446.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
24136.4\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3690.3\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
nucleolysin tiar (tia-1 related protein). [source:swissprot;acc:q01085]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4136.36\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5943.56\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.43691\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
82\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
retinal short-chain dehydrogenase/reductase 3. [source:refseq;acc:nm\_016246]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
20446.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
24136.4\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3690.3\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
small nuclear ribonucleoprotein sm d1 (snrnp core protein d1) (sm-d1) (sm-d autoantigen). [source:swissprot;acc:p13641]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4172.91\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5954.48\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.42694\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
83\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein phosphatase inhibitor 2 (ipp-2). [source:swissprot;acc:p41236]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
21644.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
18098.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3545.5\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
proto-oncogene protein c-fos (cellular oncogene fos) (g0/g1 switch regulatory protein 7). [source:swissprot;acc:p01100]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
4932.27\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
7033.29\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.42597\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
84\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
jun dimerization protein. [source:refseq;acc:nm\_130469]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
type 1 protein phosphatase inhibitor. [source:refseq;acc:nm\_025210]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
21632.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
18090\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3542.5\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
85\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
fos-related antigen 2. [source:swissprot;acc:p15408]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4941.95\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7037.11\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.42395\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ribosome biogenesis regulatory protein homolog. [source:swissprot;acc:q15050]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
21370.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
17896.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3474.3\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
86\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein fosb (g0/g1 switch regulatory protein 3). [source:swissprot;acc:p53539]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4942.49\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7037.32\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.42384\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine protein phosphatase pp1-alpha 1 catalytic subunit (ec 3.1.3.16) (pp-1a). [source:swissprot;acc:p08129]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
21370.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
17896.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3474.3\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
87\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
fos-related antigen 1 (fra-1). [source:swissprot;acc:p15407]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4944.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7038.04\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.42347\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
pre-mrna cleavage complex ii protein pcf11 (fragment). [source:swissprot;acc:o94913]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
20287.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
17083.8\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3203.4\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/